Loading…
Amrutanjan Health Care (AMRUTANJAN)₹519.85+0.40%Pharmaceuticals
Amrutanjan Health Care is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 26.0 against a peer median of 31.9, and ROCE of 25.0% against a peer median of 21.0%, and latest-quarter sales growth of 11.0% against a peer median of 13.3%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Beta Drugs | 2,089 | 39.0 | 19.0 | 18.9 | 0.11 | 0.0 | 384 | 41 | 33.0 | 58.3 | vs AMRUTANJAN |
| Indoco Remedies | 2,025 | 63.4 | 1.0 | −9.4 | 1.17 | 0.1 | 1,848 | −99 | 7.2 | — | vs AMRUTANJAN |
| Windlas Biotech | 2,007 | 30.8 | 16.0 | 12.2 | 0.06 | 0.6 | 906 | 66 | 18.2 | 0.0 | vs AMRUTANJAN |
| Venus Remedies | 1,941 | 15.9 | 21.0 | 15.7 | 0.02 | 0.7 | 769 | 103 | 13.3 | 30.0 | vs AMRUTANJAN |
| Syncom Formulations (India) | 1,885 | 21.6 | 27.1 | 20.2 | 0.00 | 0.5 | 488 | 76 | 7.7 | 56.3 | vs AMRUTANJAN |
| Amrutanjan Health Care | 1,502 | 26.0 | 25.0 | 18.5 | 0.00 | 1.1 | 503 | 58 | 11.0 | 6.6 | — |
| Accent Microcell | 1,446 | 33.0 | 25.0 | 18.7 | 0.00 | 0.2 | 349 | 44 | 51.1 | 52.9 | vs AMRUTANJAN |
| Jagsonpal Pharmaceuticals | 1,433 | 31.9 | 23.0 | 17.3 | 0.03 | 1.8 | 287 | 43 | 9.5 | 0.1 | vs AMRUTANJAN |
| Anlon Healthcare | 1,433 | 42.1 | 21.0 | 18.4 | 0.19 | 0.0 | 173 | 29 | 103.7 | 89.0 | vs AMRUTANJAN |
| Fermenta Biotech | 1,267 | 21.2 | 21.0 | 16.4 | 0.28 | 0.9 | 524 | 70 | −10.7 | −55.8 | vs AMRUTANJAN |
| Kopran | 1,252 | 50.0 | 7.0 | 4.9 | 0.29 | 1.2 | 683 | 26 | 13.9 | −10.0 | vs AMRUTANJAN |
| Peer median | 1,502 | 31.9 | 21.0 | 17.3 | 0.06 | 0.6 | 503 | 44 | 13.3 | 18.3 |
Listed companies closest to Amrutanjan Health Care in Pharmaceuticals include Beta Drugs, Indoco Remedies, Windlas Biotech, Venus Remedies, Syncom Formulations (India), Accent Microcell, Jagsonpal Pharmaceuticals, Anlon Healthcare.
Beta Drugs, with a market cap of ₹2,089 Cr.
Amrutanjan Health Care trades at a P/E of 26.0; the median of its peer set is 31.9. A P/E above or below the median is a description, not a judgement on value.
Amrutanjan Health Care's return on capital employed is 25.0%, above the peer median of 21.0%.